Johnson & Johnson: Communicable Diseases trials

The registry lists 36 Communicable Diseases studies with Johnson & Johnson as lead sponsor. 0 are open to participants now and 14 have results posted.

Early Phase 1 1Phase 1 2Phase 2 6Phase 3 19Phase 4 3No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV)TerminatedNCT04583280Phase 3Results posted
• Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus InfectionTerminatedNCT03656510Phase 2Results posted
• Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the CervixTerminatedNCT03610581Phase 1/2Results posted
• A Long-term Follow-up Study to Evaluate the Impact of Lumicitabine on the Incidence of Asthma and/or Wheezing in Infants and Children With a History of Respiratory Syncytial Virus InfectionCompletedNCT03332459Phase 2Results posted
• A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge PatientsCompletedNCT02111564Phase 3Results posted
• A Study to Assess the Efficacy and Safety of Mebendazole for the Treatment of Helminth Infections in Pediatric ParticipantsCompletedNCT02034162Phase 3Results posted
• A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious VaginosisCompletedNCT01867164Phase 3Results posted
• An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary Fungal InfectionsCompletedNCT01823289Phase 4Results posted
• A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial PneumoniaTerminatedNCT01110421Phase 3Results posted
• A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract InfectionsTerminatedNCT01110408Phase 3Results posted
• A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal InfectionsTerminatedNCT01110382Phase 3Results posted
• A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract InfectionsCompletedNCT00965848Phase 4Results posted
• A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or PneumoniaCompletedNCT00515034Phase 2Results posted
• GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.CompletedNCT00381303Phase 3Results posted
• A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe IllnessCompletedNCT05661604
• A Study of Acute Respiratory Infections in Global Outpatient SettingCompletedNCT05148780Early Phase 1
• A Study to Determine the Safety and Efficacy of Rilpivirine in Treatment-naive Indian Participants With Human Immunodeficiency Virus Type 1 (HIV-1) InfectionTerminatedNCT03563742Phase 3
• Idylla IFV-RSV Panel Clinical TestingCompletedNCT02786381
• Study to Evaluate Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection.CompletedNCT02387606Phase 2
• Study to Investigate the Pharmacokinetics and Safety of Cadazolid in Patients With Clostridium Difficile InfectionCompletedNCT02053181Phase 1
• A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV InfectionCompletedNCT01846832Phase 3
• A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract InfectionsCompletedNCT01763008
• A Study on the Safety and Effectiveness of Rilpivirine Hydrochloride (Edurant) Among Adult Filipino Patients With Human Immunodeficiency Virus Type-I InfectionWithdrawnNCT01692470
• A Complicated Skin and Soft-tissue Infection Patient RegistryCompletedNCT00737269
• A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complicated Urinary Tract InfectionsCompletedNCT00258102Phase 3
• A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Complicated Urinary Tract InfectionsCompletedNCT00258089Phase 3
• A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Uncomplicated Infections of the Skin and the Supportive Layers Beneath the SkinCompletedNCT00257062Phase 3
• A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Mild to Moderate Infections of the Skin and the Supportive Layers Beneath the SkinCompletedNCT00257036Phase 2/3
• Doripenem in the Treatment of Complicated Intra-Abdominal InfectionsCompletedNCT00229060Phase 3
• Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or PyelonephritisCompletedNCT00229021Phase 3
• Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.CompletedNCT00216450Phase 4
• Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or PyelonephritisCompletedNCT00210990Phase 3
• Doripenem in the Treatment of Complicated Intra-Abdominal InfectionsCompletedNCT00210938Phase 3
• A Comparison of the Effectiveness and Safety of Levofloxacin to That of Ciprofloxacin in Treating Complicated Urinary Tract Infection and Acute Pyelonephritis.CompletedNCT00210886Phase 3
• A Study of Itraconazole in the Prevention of Histoplasmosis, a Fungal Infection, in HIV-Infected PatientsCompletedNCT00002438Not applicable
• Study of Itraconazole in Patients With Advanced HIV InfectionCompletedNCT00002370Not applicable